KAMADA LTD (KMDA) Fundamental Analysis & Valuation

NASDAQ:KMDA • IL0010941198

8.5535 USD
-0.41 (-4.54%)
Last: Mar 11, 2026, 11:18 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This KMDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 519 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KMDA is valued quite cheap, while showing a decent growth score. This is a good combination! This makes KMDA very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. KMDA Profitability Analysis

1.1 Basic Checks

  • KMDA had positive earnings in the past year.
  • KMDA had a positive operating cash flow in the past year.
  • In multiple years KMDA reported negative net income over the last 5 years.
  • KMDA had a positive operating cash flow in 4 of the past 5 years.
KMDA Yearly Net Income VS EBIT VS OCF VS FCFKMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • KMDA has a Return On Assets of 5.42%. This is amongst the best in the industry. KMDA outperforms 91.91% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.71%, KMDA belongs to the top of the industry, outperforming 91.71% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.66%, KMDA belongs to the top of the industry, outperforming 91.91% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 19.44%.
  • The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(6.66%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROIC 6.66%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
KMDA Yearly ROA, ROE, ROICKMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 11.70%, KMDA belongs to the top of the industry, outperforming 91.52% of the companies in the same industry.
  • KMDA's Profit Margin has declined in the last couple of years.
  • KMDA has a better Operating Margin (15.88%) than 92.87% of its industry peers.
  • In the last couple of years the Operating Margin of KMDA has declined.
  • KMDA's Gross Margin of 43.75% is fine compared to the rest of the industry. KMDA outperforms 74.18% of its industry peers.
  • In the last couple of years the Gross Margin of KMDA has grown nicely.
Industry RankSector Rank
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
KMDA Yearly Profit, Operating, Gross MarginsKMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. KMDA Health Analysis

2.1 Basic Checks

  • KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for KMDA remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for KMDA has been increased compared to 5 years ago.
  • KMDA has a worse debt/assets ratio than last year.
KMDA Yearly Shares OutstandingKMDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KMDA Yearly Total Debt VS Total AssetsKMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • KMDA has an Altman-Z score of 3.88. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
  • KMDA has a better Altman-Z score (3.88) than 68.79% of its industry peers.
  • KMDA has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
  • KMDA has a Debt to FCF ratio of 0.61. This is amongst the best in the industry. KMDA outperforms 95.57% of its industry peers.
  • KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • KMDA's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. KMDA outperforms 43.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Altman-Z 3.88
ROIC/WACC0.78
WACC8.51%
KMDA Yearly LT Debt VS Equity VS FCFKMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that KMDA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.03, KMDA is in line with its industry, outperforming 47.40% of the companies in the same industry.
  • KMDA has a Quick Ratio of 2.24. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.24, KMDA is doing worse than 71.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 2.24
KMDA Yearly Current Assets VS Current LiabilitesKMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. KMDA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.57% over the past year.
  • KMDA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.60% yearly.
  • The Revenue has grown by 10.36% in the past year. This is quite good.
  • Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%

3.2 Future

  • KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.28% yearly.
  • The Revenue is expected to grow by 10.57% on average over the next years. This is quite good.
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KMDA Yearly Revenue VS EstimatesKMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
KMDA Yearly EPS VS EstimatesKMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. KMDA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.76 indicates a rather expensive valuation of KMDA.
  • KMDA's Price/Earnings ratio is rather cheap when compared to the industry. KMDA is cheaper than 93.06% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of KMDA to the average of the S&P500 Index (26.25), we can say KMDA is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 17.84, the valuation of KMDA can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.61% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (24.39), we can say KMDA is valued slightly cheaper.
Industry RankSector Rank
PE 23.76
Fwd PE 17.84
KMDA Price Earnings VS Forward Price EarningsKMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaper than 96.53% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, KMDA is valued cheaper than 94.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.42
EV/EBITDA 10.57
KMDA Per share dataKMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of KMDA may justify a higher PE ratio.
  • A more expensive valuation may be justified as KMDA's earnings are expected to grow with 31.28% in the coming years.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. KMDA Dividend Analysis

5.1 Amount

  • KMDA has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.25, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.46% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, KMDA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

  • KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KMDA Yearly Dividends per shareKMDA Yearly Dividends per shareYearly Dividends per share 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y35.79%
EPS Next 3Y31.28%
KMDA Yearly Income VS Free CF VS DividendKMDA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

KMDA Fundamentals: All Metrics, Ratios and Statistics

KAMADA LTD

NASDAQ:KMDA (3/11/2026, 11:18:05 AM)

8.5535

-0.41 (-4.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-11
Earnings (Next)N/A
Inst Owners10.63%
Inst Owner Change-10.37%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap493.37M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (55.02%)
Short Float %0.53%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)0%
PT rev (3m)-11.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 23.76
Fwd PE 17.84
P/S 2.82
P/FCF 26.42
P/OCF 17.06
P/B 1.86
P/tB 2.1
EV/EBITDA 10.57
EPS(TTM)0.36
EY4.21%
EPS(NY)0.48
Fwd EY5.6%
FCF(TTM)0.32
FCFY3.78%
OCF(TTM)0.5
OCFY5.86%
SpS3.03
BVpS4.6
TBVpS4.07
PEG (NY)0.54
PEG (5Y)N/A
Graham Number6.1
Profitability
Industry RankSector Rank
ROA 5.42%
ROE 7.71%
ROCE 8.43%
ROIC 6.66%
ROICexc 8.52%
ROICexgc 9.66%
OM 15.88%
PM (TTM) 11.7%
GM 43.75%
FCFM 10.68%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.61
Debt/EBITDA 0.22
Cap/Depr 66.53%
Cap/Sales 5.86%
Interest Coverage 35.82
Cash Conversion 67%
Profit Quality 91.33%
Current Ratio 4.03
Quick Ratio 2.24
Altman-Z 3.88
F-Score7
WACC8.51%
ROIC/WACC0.78
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y35.79%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.88%
Revenue Next 3Y10.57%
Revenue Next 5YN/A
EBIT growth 1Y56.45%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y937.39%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y334.95%
OCF growth 3YN/A
OCF growth 5Y11.54%

KAMADA LTD / KMDA FAQ

Can you provide the ChartMill fundamental rating for KAMADA LTD?

ChartMill assigns a fundamental rating of 6 / 10 to KMDA.


What is the valuation status for KMDA stock?

ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.


Can you provide the profitability details for KAMADA LTD?

KAMADA LTD (KMDA) has a profitability rating of 7 / 10.


How financially healthy is KAMADA LTD?

The financial health rating of KAMADA LTD (KMDA) is 6 / 10.